- Report
- September 2023
- 120 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- May 2024
- 135 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- May 2024
- 137 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- April 2024
- 185 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- January 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4719EUR$4,950USD£4,022GBP
- Report
- March 2018
- 179 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- January 2022
- 60 Pages
Global
From €3766EUR$3,950USD£3,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3766EUR$3,950USD£3,210GBP
- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- June 2023
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- August 2022
United States
From €1849EUR$1,940USD£1,576GBP
- Report
- August 2022
Global
From €753EUR$790USD£642GBP
- Report
- August 2021
Global
From €3804EUR$3,990USD£3,242GBP
- Report
- August 2021
Europe
From €3260EUR$3,420USD£2,779GBP
- Report
- February 2021
Global
From €2822EUR$2,960USD£2,405GBP
- Clinical Trials
- January 2020
- 318 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Report
- August 2022
- 376 Pages
Global
From €2383EUR$2,500USD£2,031GBP
The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more